Madsen JS - Search Results

1

Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor.

Mojsoska B, Larsen S, Olsen DA, Madsen JS, Brandslund I, Alatraktchi FA. Mojsoska B, et al. Among authors: madsen js. Sensors (Basel). 2021 Jan 8;21(2):390. doi: 10.3390/s21020390. Sensors (Basel). 2021. PMID: 33429915 Free PMC article.

2

Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting.

Sørensen PD, Jakobsen EH, Langkjer ST, Bokmand S, Østergaard B, Olsen DA, Madsen JS, Brandslund I. Sørensen PD, et al. Among authors: madsen js. Clin Chem Lab Med. 2009;47(9):1117-23. doi: 10.1515/CCLM.2009.241. Clin Chem Lab Med. 2009. PMID: 19728854

3

Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment.

Christensen H, Lauterlein JJ, Sørensen PD, Petersen ER, Madsen JS, Brandslund I. Christensen H, et al. Among authors: madsen js. Telemed J E Health. 2011 Apr;17(3):169-76. doi: 10.1089/tmj.2010.0128. Epub 2011 Jan 23. Telemed J E Health. 2011. PMID: 21254841 Free PMC article. Clinical Trial.

4

Serum HER-2/ECD analysis in monitoring breast cancer patients.

Sørensen PD, Madsen JS, Brandslund I. Sørensen PD, et al. Among authors: madsen js. Clin Chem Lab Med. 2011 Sep 23;50(1):175-6. doi: 10.1515/CCLM.2011.722. Clin Chem Lab Med. 2011. PMID: 21942810 No abstract available.

5

Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer.

Pedersen AC, Sørensen PD, Jacobsen EH, Madsen JS, Brandslund I. Pedersen AC, et al. Among authors: madsen js. Clin Chem Lab Med. 2013 Jul;51(7):1511-9. doi: 10.1515/cclm-2012-0488. Clin Chem Lab Med. 2013. PMID: 23403727

6

Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy.

Bechmann T, Olsen DA, Jakobsen EH, Madsen JS, Brandslund I, Jylling AM, Steffensen KD, Jakobsen A. Bechmann T, et al. Among authors: madsen js. Oncol Rep. 2013 Apr;29(4):1475-82. doi: 10.3892/or.2013.2289. Epub 2013 Feb 15. Oncol Rep. 2013. PMID: 23417164 Free article.

7

Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancer.

Petersen ER, Sørensen PD, Jakobsen EH, Madsen JS, Brandslund I. Petersen ER, et al. Among authors: madsen js. Clin Chem Lab Med. 2013 Jul;51(7):1483-92. doi: 10.1515/cclm-2012-0558. Clin Chem Lab Med. 2013. PMID: 23420288

8

Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients.

Sørensen PD, Jakobsen EH, Madsen JS, Petersen EB, Andersen RF, Østergaard B, Brandslund I. Sørensen PD, et al. Among authors: madsen js. J Cancer Res Clin Oncol. 2013 Jun;139(6):1005-13. doi: 10.1007/s00432-013-1411-7. Epub 2013 Mar 13. J Cancer Res Clin Oncol. 2013. PMID: 23483255

9

Predicting brain metastases of breast cancer based on serum S100B and serum HER2.

Bechmann T, Madsen JS, Brandslund I, Lund ED, Ormstrup T, Jakobsen EH, Jylling AM, Steffensen KD, Jakobsen A. Bechmann T, et al. Among authors: madsen js. Oncol Lett. 2013 Nov;6(5):1265-1270. doi: 10.3892/ol.2013.1536. Epub 2013 Aug 19. Oncol Lett. 2013. PMID: 24179506 Free PMC article.

10

New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer.

Horn P, Jakobsen EH, Madsen JS, Brandslund I. Horn P, et al. Among authors: madsen js. Transl Oncol. 2014 Dec;7(6):694-701. doi: 10.1016/j.tranon.2014.09.010. Transl Oncol. 2014. PMID: 25500078 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page